OR WAIT null SECS
May 23, 2018
The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.
May 17, 2018
Internationalization and regulatory reform are driving growth and investment China.
May 16, 2018
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 15, 2018
The BioIndustry Association has called on the British government to introduce a new venture capital fund structure that will enable the public to invest in the United Kingdom’s biotech revolution.
May 14, 2018
Barriers impede biosimilar market entry into the United States despite the Biologics Price Competition and Innovation Act.
May 09, 2018
Takeda expands its global and therapy base with announced acquisition of Shire.
May 02, 2018
A skilled workforce is needed to deliver on technology’s promising medical advances.
April 20, 2018
LNC Therapeutics has appointed a new CEO and is strengthening its R&D for gut microbiome-based drugs.
April 19, 2018
The transaction is part of Merck KGaA’s strategy to actively shape its product portfolio and focus on innovation-driven business.
Global investment firm Advent to acquire and invest in Sanofi’s European generics business, Zentiva, to boost its position in European market.